1999
DOI: 10.1016/s0272-6386(99)70083-1
|View full text |Cite
|
Sign up to set email alerts
|

Drug-induced acute interstitial nephritis in renal allografts: Histopathologic features and clinical course in six patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2003
2003
2018
2018

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 35 publications
(14 citation statements)
references
References 19 publications
0
12
0
Order By: Relevance
“…It seems reasonable to additionally screen patients from groups 1‐3 for other atypical organisms (chlamydia, gonococci, mycobacteria, and possibly herpes simplex virus). However, non‐infectious causes such as drug‐induced acute interstitial nephritis, renal allograft rejection, or polyomavirus nephropathy are important differential diagnoses in patients from group 3, and often these patients will require an allograft biopsy.…”
Section: Discussionmentioning
confidence: 99%
“…It seems reasonable to additionally screen patients from groups 1‐3 for other atypical organisms (chlamydia, gonococci, mycobacteria, and possibly herpes simplex virus). However, non‐infectious causes such as drug‐induced acute interstitial nephritis, renal allograft rejection, or polyomavirus nephropathy are important differential diagnoses in patients from group 3, and often these patients will require an allograft biopsy.…”
Section: Discussionmentioning
confidence: 99%
“…Their graft function was improved after anti‐infection therapy. Other than infective factors, rare cases of GIN have been described in renal allografts in association with the recurrence of sarcoidosis and medication . Collectively, these reports indicated that infection was the main causative factor of GIN in renal allografts, which differed from the native kidney.…”
Section: Discussionmentioning
confidence: 99%
“…The true incidence of nephrotoxicity is poorly described in the literature, which is limited to case series and reports often involving patients with underlying renal abnormalities. [45][46][47] This misconception of high rates of nephrotoxicity associated with TMP-SMX use is enhanced by the fact that earlier generation, less-soluble sulfonamides (e.g., sulfadiazine) used in very high doses were associated with crystalluria. 48 However, crystalluria does not usually occur with newer agents, including sulfamethoxazole.…”
Section: Trimethoprim-sulfamethoxazolementioning
confidence: 99%